Direct-to-consumer DNA testing firm 23andMe Holding Co. said on Friday it would buy privately held company Lemonaid Health Inc. for $400 million in a cash-and-stock deal, as it looks to expand into telemedicine.
Lemonaid Health offers patients direct …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
